journal article·2017-02-28Open access

Advancement of the Emerging Field of RNA Nanotechnology

Daniel Jasinski, Farzin Haque, Daniel W Binzel, Peixuan Guo

ACS Nano· Volume 11· Issue 2

Abstract

The field of RNA nanotechnology has advanced rapidly during the past decade. A variety of programmable RNA nanoparticles with defined shape, size, and stoichiometry have been developed for diverse applications in nanobiotechnology. The rising popularity of RNA nanoparticles is due to a number of factors: (1) removing the concern of RNA degradation in vitro and in vivo by introducing chemical modification into nucleotides without significant alteration of the RNA property in folding and self-assembly; (2) confirming the concept that RNA displays very high thermodynamic stability and is suitable for in vivo trafficking and other applications; (3) obtaining the knowledge to tune the immunogenic properties of synthetic RNA constructs for in vivo applications; (4) increased understanding of the 4D structure and intermolecular interaction of RNA molecules; (5) developing methods to control shape, size, and stoichiometry of RNA nanoparticles; (6) increasing knowledge of regulation and processing functions of RNA in cells; (7) decreasing cost of RNA production by biological and chemical synthesis; and (8) proving the concept that RNA is a safe and specific therapeutic modality for cancer and other diseases with little or no accumulation in vital organs. Other applications of RNA nanotechnology, such as adapting them to construct 2D, 3D, and 4D structures for use in tissue engineering, biosensing, resistive biomemory, and potential computer logic gate modules, have stimulated the interest of the scientific community. This review aims to outline the current state of the art of RNA nanoparticles as programmable smart complexes and offers perspectives on the promising avenues of research in this fast-growing field.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA and protein synthesis mechanisms · Advanced biosensing and bioanalysis techniques · RNA modifications and cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Pharmacy, Division of Pharmaceutics and Pharmaceutical Chemistry; College of Medicine, Department of Physiology & Cell Biology; and Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio 43210, United States

Funding

National Cancer Institute · National Institute of Biomedical Imaging and Bioengineering

References (100+)

Show source-provided references
1. 10.1038/nnano.2010.23110.1038/nnano.2010.231 ↗
2. 10.1016/S1097-2765(00)80124-010.1016/S1097-2765(00)80124-0 ↗
3. 10.1089/hum.2005.16.109710.1089/hum.2005.16.1097 ↗
4. 10.1126/science.120693810.1126/science.1206938 ↗
5. 10.1038/nmat325310.1038/nmat3253 ↗
6. 10.1002/anie.20150737510.1002/anie.201507375 ↗
7. 10.1002/stem.46010.1002/stem.460 ↗
8. 10.1038/sj.gt.330200210.1038/sj.gt.3302002 ↗
9. 10.1073/pnas.91.18.870510.1073/pnas.91.18.8705 ↗
10. 10.1093/nar/gkm84210.1093/nar/gkm842 ↗
11. 10.1074/jbc.M30651120010.1074/jbc.M306511200 ↗
12. 10.1021/bi00035a02910.1021/bi00035a029 ↗
13. 10.1093/nar/21.9.205110.1093/nar/21.9.2051 ↗
14. 10.1093/nar/gkf54010.1093/nar/gkf540 ↗
15. 10.1017/S135583820100251510.1017/S1355838201002515 ↗
16. 10.1016/j.sbi.2006.05.00910.1016/j.sbi.2006.05.009 ↗
17. 10.1016/S0959-440X(03)00076-910.1016/S0959-440X(03)00076-9 ↗
18. 10.1002/adma.20160318010.1002/adma.201603180 ↗
19. 10.1007/978-1-4939-2730-2_1510.1007/978-1-4939-2730-2_15 ↗
20. 10.1021/nn500625410.1021/nn5006254 ↗
21. 10.1093/nar/gku51610.1093/nar/gku516 ↗
22. 10.1021/nn502160s10.1021/nn502160s ↗
23. 10.1016/j.sbi.2007.05.00310.1016/j.sbi.2007.05.003 ↗
24. 10.1101/cshperspect.a00356610.1101/cshperspect.a003566 ↗
25. 10.1038/nrm383810.1038/nrm3838 ↗
26. 10.1016/S0092-8674(00)81413-010.1016/S0092-8674(00)81413-0 ↗
27. 10.1093/nar/gkf48110.1093/nar/gkf481 ↗
28. 10.1093/nar/29.2.45510.1093/nar/29.2.455 ↗
29. 10.1002/wrna.118510.1002/wrna.1185 ↗
30. 10.1016/j.sbi.2006.07.00110.1016/j.sbi.2006.07.001 ↗
31. 10.1016/S1359-0278(96)00037-510.1016/S1359-0278(96)00037-5 ↗
32. 10.1126/science.110468610.1126/science.1104686 ↗
33. 10.1126/science.110675410.1126/science.1106754 ↗
34. 10.1038/mt.2011.3510.1038/mt.2011.35 ↗
35. 10.1038/nnano.2011.10510.1038/nnano.2011.105 ↗
36. 10.1016/j.nantod.2012.06.01010.1016/j.nantod.2012.06.010 ↗
37. 10.1038/3505706210.1038/35057062 ↗
38. 10.1126/science.111680010.1126/science.1116800 ↗
39. 10.1016/j.cell.2013.03.01910.1016/j.cell.2013.03.019 ↗
40. 10.1016/0022-5193(82)90002-910.1016/0022-5193(82)90002-9 ↗
41. 10.1126/science.126090110.1126/science.1260901 ↗
42. 10.1146/annurev-biochem-060308-10224410.1146/annurev-biochem-060308-102244 ↗
43. 10.1038/nature0797110.1038/nature07971 ↗
44. 10.1038/nnano.2008.310.1038/nnano.2008.3 ↗
45. 10.1021/acs.bioconjchem.5b0019410.1021/acs.bioconjchem.5b00194 ↗
46. 10.1038/nature0458610.1038/nature04586 ↗
47. 10.1021/nl901165f10.1021/nl901165f ↗
48. 10.1126/science.121408110.1126/science.1214081 ↗
49. 10.1126/science.117425110.1126/science.1174251 ↗
50. 10.1038/nnano.2010.10710.1038/nnano.2010.107 ↗
51. 10.1038/301578a010.1038/301578a0 ↗
52. 10.1093/emboj/20.3.54110.1093/emboj/20.3.541 ↗
53. Matsumura Y. · Cancer Res. · 1986 · 46 · 6387
54. 10.1158/0008-5472.CAN-12-456110.1158/0008-5472.CAN-12-4561 ↗
55. 10.1016/j.jconrel.2011.09.06310.1016/j.jconrel.2011.09.063 ↗
56. 10.1093/nar/gkt88510.1093/nar/gkt885 ↗
57. 10.1016/j.ymeth.2011.02.00810.1016/j.ymeth.2011.02.008 ↗
58. 10.1016/j.ymthe.2006.01.00110.1016/j.ymthe.2006.01.001 ↗
59. 10.1261/rna.037002.11210.1261/rna.037002.112 ↗
60. 10.1021/acsnano.5b0247110.1021/acsnano.5b02471 ↗
61. 10.1038/srep1072610.1038/srep10726 ↗
62. 10.1021/acsnano.5b0006710.1021/acsnano.5b00067 ↗
63. 10.18632/oncotarget.363210.18632/oncotarget.3632 ↗
64. 10.1039/C4NR01794C10.1039/C4NR01794C ↗
65. 10.1146/annurev.immunol.20.100301.06484210.1146/annurev.immunol.20.100301.064842 ↗
66. 10.1038/nrd205910.1038/nrd2059 ↗
67. 10.1016/j.addr.2008.12.00810.1016/j.addr.2008.12.008 ↗
68. 10.1038/nrc323710.1038/nrc3237 ↗
69. 10.1146/annurev-chembioeng-061010-11413310.1146/annurev-chembioeng-061010-114133 ↗
70. 10.1038/nbt108110.1038/nbt1081 ↗
71. 10.1016/j.ymthe.2005.11.00210.1016/j.ymthe.2005.11.002 ↗
72. 10.1038/nbt112210.1038/nbt1122 ↗
73. 10.1126/science.113250510.1126/science.1132505 ↗
74. 10.1016/j.jmb.2006.09.03410.1016/j.jmb.2006.09.034 ↗
75. 10.1038/nm119110.1038/nm1191 ↗
76. 10.1021/bi401702210.1021/bi4017022 ↗
77. 10.1089/oli.2008.016410.1089/oli.2008.0164 ↗
78. 10.1016/j.drudis.2008.05.00710.1016/j.drudis.2008.05.007 ↗
79. 10.1021/nn102465810.1021/nn1024658 ↗
80. 10.1093/nar/gki19310.1093/nar/gki193 ↗
81. 10.1089/nat.2014.050610.1089/nat.2014.0506 ↗
82. 10.1021/bi100950310.1021/bi1009503 ↗
83. 10.1093/nar/gkh93610.1093/nar/gkh936 ↗
84. 10.2174/09298670577437066410.2174/092986705774370664 ↗
85. 10.1021/jacs.5b0548110.1021/jacs.5b05481 ↗
86. 10.1021/ja503258410.1021/ja5032584 ↗
87. 10.1021/jacs.5b0023610.1021/jacs.5b00236 ↗
88. 10.1021/ja209932610.1021/ja2099326 ↗
89. 10.1021/bi400896310.1021/bi4008963 ↗
90. 10.1055/s-0034-138069810.1055/s-0034-1380698 ↗
91. 10.1002/1521-3765(20000804)6:15<2687::AID-CHEM2687>3.0.CO;2-U10.1002/1521-3765(20000804)6:15<2687::AID-CHEM2687>3.0.CO;2-U ↗
92. 10.1021/bi060307w10.1021/bi060307w ↗
93. 10.1093/nar/30.9.191110.1093/nar/30.9.1911 ↗
94. 10.1038/ng.78610.1038/ng.786 ↗
95. 10.1021/jm049167j10.1021/jm049167j ↗
96. 10.1261/rna.53890710.1261/rna.538907 ↗
97. 10.1126/science.310712410.1126/science.3107124 ↗
98. 10.1021/nl049449710.1021/nl0494497 ↗
99. 10.1038/nprot.2013.09710.1038/nprot.2013.097 ↗
100. 10.1261/rna.039438.11310.1261/rna.039438.113 ↗